{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:30:34Z","timestamp":1782732634040,"version":"3.54.5"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T00:00:00Z","timestamp":1377561600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/nrgastro.2013.150","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T13:18:50Z","timestamp":1377609530000},"page":"19-27","source":"Crossref","is-referenced-by-count":29,"title":["The '\u2013omics' revolution and oesophageal adenocarcinoma"],"prefix":"10.1038","volume":"11","author":[{"given":"Jamie M. J.","family":"Weaver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn S.","family":"Ross-Innes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca C.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,27]]},"reference":[{"key":"BFnrgastro2013150_CR1","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1158\/1055-9965.EPI-10-0012","volume":"19","author":"H Pohl","year":"2010","unstructured":"Pohl, H., Sirovich, B. & Welch, H. G. Esophageal adenocarcinoma incidence: are we reaching the peak? Cancer Epidemiol. Biomarkers Prev. 19, 1468\u20131470 (2010).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"BFnrgastro2013150_CR2","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","volume":"366","author":"P van Hagen","year":"2012","unstructured":"van Hagen, P.  et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N. Engl. J. Med. 366, 2074\u20132084 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2013150_CR3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199903183401101","volume":"340","author":"J Lagergren","year":"1999","unstructured":"Lagergren, J., Bergstrom, R., Lindgren, A. & Nyren, O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 340, 825\u2013831 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2013150_CR4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1442-2050.2007.00638.x","volume":"20","author":"P Chandrasoma","year":"2007","unstructured":"Chandrasoma, P., Wickramasinghe, K., Ma, Y. & DeMeester, T. Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia? Dis. Esophagus 20, 36\u201341 (2007).","journal-title":"Dis. Esophagus"},{"key":"BFnrgastro2013150_CR5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00000658-200009000-00007","volume":"232","author":"J Rudiger Siewert","year":"2000","unstructured":"Rudiger Siewert, J., Feith, M., Werner, M. & Stein, H. J. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical\/topographic classification in 1,002 consecutive patients. Ann. Surg. 232, 353\u2013361 (2000).","journal-title":"Ann. Surg."},{"key":"BFnrgastro2013150_CR6","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/modpathol.2011.77","volume":"24","author":"EG Demicco","year":"2011","unstructured":"Demicco, E. G.  et al. The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma. Mod. Pathol. 24, 1177\u20131190 (2011).","journal-title":"Mod. Pathol."},{"key":"BFnrgastro2013150_CR7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/gut.2007.137364","volume":"57","author":"MH Derakhshan","year":"2008","unstructured":"Derakhshan, M. H.  et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut 57, 298\u2013305 (2008).","journal-title":"Gut"},{"key":"BFnrgastro2013150_CR8","doi-asserted-by":"crossref","first-page":"c6280","DOI":"10.1136\/bmj.c6280","volume":"341","author":"J Lagergren","year":"2010","unstructured":"Lagergren, J. & Lagergren, P. Oesophageal cancer. BMJ 341, c6280 (2010).","journal-title":"BMJ"},{"key":"BFnrgastro2013150_CR9","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.2408","volume":"44","author":"Z Su","year":"2012","unstructured":"Su, Z.  et al. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat. Genet. 44, 1131\u20131136 (2012).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2013150_CR10","doi-asserted-by":"crossref","first-page":"c4372","DOI":"10.1136\/bmj.c4372","volume":"341","author":"SR Kadri","year":"2010","unstructured":"Kadri, S. R.  et al. Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study. BMJ 341, c4372 (2010).","journal-title":"BMJ"},{"key":"BFnrgastro2013150_CR11","unstructured":"Cancer Prevention Trials Unit. BEST2. Cancer Prevention Trials Unit \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrgastro2013150_CR12","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","volume":"365","author":"F Hvid-Jensen","year":"2011","unstructured":"Hvid-Jensen, F., Pedersen, L., Drewes, A. M., Sorensen, H. T. & Funch-Jensen, P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N. Engl. J. Med. 365, 1375\u20131383 (2011).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2013150_CR13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jnci\/djr203","volume":"103","author":"S Bhat","year":"2011","unstructured":"Bhat, S.  et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J. Natl Cancer Inst. 103, 1049\u20131057 (2011).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrgastro2013150_CR14","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1365-2559.2007.02706.x","volume":"50","author":"M Kerkhof","year":"2007","unstructured":"Kerkhof, M.  et al. Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology 50, 920\u2013927 (2007).","journal-title":"Histopathology"},{"key":"BFnrgastro2013150_CR15","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/ajg.2010.171","volume":"105","author":"WL Curvers","year":"2010","unstructured":"Curvers, W. L.  et al. Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated. Am. J. Gastroenterol. 105, 1523\u20131530 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2013150_CR16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.gastro.2012.01.013","volume":"142","author":"S Varghese","year":"2012","unstructured":"Varghese, S., Lao-Sirieix, P. & Fitzgerald, R. C. Identification and clinical implementation of biomarkers for Barrett's esophagus. Gastroenterology 142, 435\u2013441 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013150_CR17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4137\/BBI.S311","volume":"1","author":"FM Selaru","year":"2007","unstructured":"Selaru, F. M.  et al. Beyond field effect: analysis of shrunken centroids in normal esophageal epithelia detects concomitant esophageal adenocarcinoma. Bioinform. Biol. Insights 1, 127\u2013136 (2007).","journal-title":"Bioinform. Biol. Insights"},{"key":"BFnrgastro2013150_CR18","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/ajg.2010.2","volume":"105","author":"GA Prasad","year":"2010","unstructured":"Prasad, G. A., Bansal, A., Sharma, P. & Wang, K. K. Predictors of progression in Barrett's esophagus: current knowledge and future directions. Am. J. Gastroenterol. 105, 1490\u20131502 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2013150_CR19","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/sj.bjc.6605688","volume":"102","author":"JM Dunn","year":"2010","unstructured":"Dunn, J. M.  et al. Image cytometry accurately detects DNA ploidy abnormalities and predicts late relapse to high-grade dysplasia and adenocarcinoma in Barrett's oesophagus following photodynamic therapy. Br. J. Cancer 102, 1608\u20131617 (2010).","journal-title":"Br. J. Cancer"},{"key":"BFnrgastro2013150_CR20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S. L.  et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413\u2013421 (2012).","journal-title":"Nat. Biotechnol."},{"key":"BFnrgastro2013150_CR21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/bioinformatics\/btr670","volume":"28","author":"V Boeva","year":"2012","unstructured":"Boeva, V.  et al. Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data. Bioinformatics 28, 423\u2013425 (2012).","journal-title":"Bioinformatics"},{"key":"BFnrgastro2013150_CR22","doi-asserted-by":"crossref","first-page":"e59128","DOI":"10.1371\/journal.pone.0059128","volume":"8","author":"J Duan","year":"2013","unstructured":"Duan, J., Zhang, J. G., Deng, H. W. & Wang, Y. P. Comparative studies of copy number variation detection methods for next-generation sequencing technologies. PLoS ONE 8, e59128 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2013150_CR23","doi-asserted-by":"crossref","first-page":"111ra121","DOI":"10.1126\/scitranslmed.3003161","volume":"3","author":"S Roychowdhury","year":"2011","unstructured":"Roychowdhury, S.  et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci. Transl. Med. 3, 111ra121 (2011).","journal-title":"Sci. Transl. Med."},{"key":"BFnrgastro2013150_CR24","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.24620","volume":"125","author":"T Akagi","year":"2009","unstructured":"Akagi, T.  et al. Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma. Int. J. Cancer 125, 2349\u20132359 (2009).","journal-title":"Int. J. Cancer"},{"key":"BFnrgastro2013150_CR25","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0002-9440(10)64760-8","volume":"156","author":"AK Walch","year":"2000","unstructured":"Walch, A. K.  et al. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. Am. J. Pathol. 156, 555\u2013566 (2000).","journal-title":"Am. J. Pathol."},{"key":"BFnrgastro2013150_CR26","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/gcc.20435","volume":"46","author":"LA Lai","year":"2007","unstructured":"Lai, L. A.  et al. Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH. Genes Chromosomes Cancer 46, 532\u2013542 (2007).","journal-title":"Genes Chromosomes Cancer"},{"key":"BFnrgastro2013150_CR27","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1158\/1078-0432.CCR-08-2494","volume":"15","author":"TG Paulson","year":"2009","unstructured":"Paulson, T. G.  et al. Chromosomal instability and copy number alterations in Barrett's esophagus and esophageal adenocarcinoma. Clin. Cancer Res. 15, 3305\u20133314 (2009).","journal-title":"Clin. Cancer Res."},{"key":"BFnrgastro2013150_CR28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2353\/jmoldx.2006.050118","volume":"8","author":"SM Brankley","year":"2006","unstructured":"Brankley, S. M.  et al. The development of a fluorescence in situ hybridization assay for the detection of dysplasia and adenocarcinoma in Barrett's esophagus. J. Mol. Diagn. 8, 260\u2013267 (2006).","journal-title":"J. Mol. Diagn."},{"key":"BFnrgastro2013150_CR29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0016-5107(04)01687-6","volume":"60","author":"GW Falk","year":"2004","unstructured":"Falk, G. W.  et al. Fluorescence in situ hybridization of cytologic specimens from Barrett's esophagus: a pilot feasibility study. Gastrointest. Endosc. 60, 280\u2013284 (2004).","journal-title":"Gastrointest. Endosc."},{"key":"BFnrgastro2013150_CR30","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1158\/1055-9965.EPI-07-2734","volume":"17","author":"AM Rygiel","year":"2008","unstructured":"Rygiel, A. M.  et al. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus. Cancer Epidemiol. Biomarkers Prev. 17, 1380\u20131385 (2008).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"BFnrgastro2013150_CR31","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1158\/2159-8290.CD-12-0189","volume":"2","author":"N Agrawal","year":"2012","unstructured":"Agrawal, N.  et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov. 2, 899\u2013905 (2012).","journal-title":"Cancer Discov."},{"key":"BFnrgastro2013150_CR32","first-page":"3410","volume":"61","author":"CA Eads","year":"2001","unstructured":"Eads, C. A.  et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res. 61, 3410\u20133418 (2001).","journal-title":"Cancer Res."},{"key":"BFnrgastro2013150_CR33","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1158\/1078-0432.CCR-12-2880","volume":"19","author":"MA Alvi","year":"2013","unstructured":"Alvi, M. A.  et al. DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus. Clin. Cancer Res. 19, 878\u2013888 (2013).","journal-title":"Clin. Cancer Res."},{"key":"BFnrgastro2013150_CR34","first-page":"382","volume":"5","author":"A Agarwal","year":"2012","unstructured":"Agarwal, A.  et al. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma. Int. J. Clin. Exp. Pathol. 5, 382\u2013396 (2012).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"BFnrgastro2013150_CR35","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1053\/j.gastro.2013.01.019","volume":"144","author":"W Wu","year":"2013","unstructured":"Wu, W.  et al. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 144, 956\u2013966 (2013).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013150_CR36","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1093\/nar\/28.8.e32","volume":"28","author":"CA Eads","year":"2000","unstructured":"Eads, C. A.  et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res. 28, E32 (2000).","journal-title":"Nucleic Acids Res."},{"key":"BFnrgastro2013150_CR37","doi-asserted-by":"crossref","first-page":"L5","DOI":"10.1530\/ERC-11-0364","volume":"19","author":"R Agarwal","year":"2012","unstructured":"Agarwal, R.  et al. Epigenomic program of Barrett's-associated neoplastic progression reveals possible involvement of insulin signaling pathways. Endocr. Relat Cancer 19, L5\u2013L9 (2012).","journal-title":"Endocr. Relat Cancer"},{"key":"BFnrgastro2013150_CR38","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1038\/sj.onc.1208598","volume":"24","author":"K Schulmann","year":"2005","unstructured":"Schulmann, K.  et al. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk. Oncogene 24, 4138\u20134148 (2005).","journal-title":"Oncogene"},{"key":"BFnrgastro2013150_CR39","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0140-6736(93)90938-D","volume":"341","author":"ES Group","year":"1993","unstructured":"Group, E. S. An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet 341, 1359\u20131362 (1993).","journal-title":"Lancet"},{"key":"BFnrgastro2013150_CR40","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature11053","volume":"486","author":"T Yatsunenko","year":"2012","unstructured":"Yatsunenko, T.  et al. Human gut microbiome viewed across age and geography. Nature 486, 222\u2013227 (2012).","journal-title":"Nature"},{"key":"BFnrgastro2013150_CR41","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/j.gastro.2009.04.046","volume":"137","author":"L Yang","year":"2009","unstructured":"Yang, L.  et al. Inflammation and intestinal metaplasia of the distal esophagus are associated with alterations in the microbiome. Gastroenterology 137, 588\u2013597 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013150_CR42","doi-asserted-by":"crossref","first-page":"e42938","DOI":"10.1371\/journal.pone.0042938","volume":"7","author":"SA Fillon","year":"2012","unstructured":"Fillon, S. A.  et al. Novel device to sample the esophageal microbiome--the esophageal string test. PLoS ONE 7, e42938 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2013150_CR43","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1101\/gr.126573.111","volume":"22","author":"AD Kostic","year":"2012","unstructured":"Kostic, A. D.  et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292\u2013298 (2012).","journal-title":"Genome Res."},{"key":"BFnrgastro2013150_CR44","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00535-009-0082-2","volume":"44","author":"J Wang","year":"2009","unstructured":"Wang, J.  et al. Differential gene expression in normal esophagus and Barrett's esophagus. J. Gastroenterol. 44, 897\u2013911 (2009).","journal-title":"J. Gastroenterol."},{"key":"BFnrgastro2013150_CR45","first-page":"3493","volume":"62","author":"Y Xu","year":"2002","unstructured":"Xu, Y.  et al. Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer. Cancer Res. 62, 3493\u20133497 (2002).","journal-title":"Cancer Res."},{"key":"BFnrgastro2013150_CR46","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1053\/j.gastro.2010.05.080","volume":"139","author":"CJ Peters","year":"2010","unstructured":"Peters, C. J.  et al. A 4-gene signature predicts survival of patients with resected adenocarcinoma of the esophagus, junction, and gastric cardia. Gastroenterology 139, 1995\u20132004 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013150_CR47","doi-asserted-by":"crossref","first-page":"e15074","DOI":"10.1371\/journal.pone.0015074","volume":"5","author":"SM Kim","year":"2010","unstructured":"Kim, S. M.  et al. Prognostic biomarkers for esophageal adenocarcinoma identified by analysis of tumor transcriptome. PLoS ONE 5, e15074 (2010).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2013150_CR48","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1158\/0008-5472.CAN-04-2490","volume":"65","author":"ET Kimchi","year":"2005","unstructured":"Kimchi, E. T.  et al. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. Cancer Res. 65, 3146\u20133154 (2005).","journal-title":"Cancer Res."},{"key":"BFnrgastro2013150_CR49","doi-asserted-by":"crossref","first-page":"e22513","DOI":"10.1371\/journal.pone.0022513","volume":"6","author":"DJ Nancarrow","year":"2011","unstructured":"Nancarrow, D. J.  et al. Whole genome expression array profiling highlights differences in mucosal defense genes in Barrett's esophagus and esophageal adenocarcinoma. PLoS ONE 6, e22513 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2013150_CR50","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1053\/j.gastro.2006.04.026","volume":"131","author":"Y Hao","year":"2006","unstructured":"Hao, Y.  et al. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenterology 131, 925\u2013933 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013150_CR51","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jtcvs.2008.08.052","volume":"137","author":"ZT Hammoud","year":"2009","unstructured":"Hammoud, Z. T.  et al. Differential gene expression profiling of esophageal adenocarcinoma. J. Thorac. Cardiovasc. Surg. 137, 829\u2013834 (2009).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrgastro2013150_CR52","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/path.1576","volume":"203","author":"B Albrecht","year":"2004","unstructured":"Albrecht, B.  et al. Array-based comparative genomic hybridization for the detection of DNA sequence copy number changes in Barrett's adenocarcinoma. J. Pathol. 203, 780\u2013788 (2004).","journal-title":"J. Pathol."},{"key":"BFnrgastro2013150_CR53","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1158\/0008-5472.CAN-07-6710","volume":"68","author":"DJ Nancarrow","year":"2008","unstructured":"Nancarrow, D. J.  et al. Genome-wide copy number analysis in esophageal adenocarcinoma using high-density single-nucleotide polymorphism arrays. Cancer Res. 68, 4163\u20134172 (2008).","journal-title":"Cancer Res."},{"key":"BFnrgastro2013150_CR54","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1158\/1940-6207.CAPR-09-0265","volume":"3","author":"J Gu","year":"2010","unstructured":"Gu, J.  et al. Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis. Cancer Prev. Res. (Phila) 3, 1176\u20131186 (2010).","journal-title":"Cancer Prev. Res. (Phila)"},{"issue":"Suppl. 2","key":"BFnrgastro2013150_CR55","first-page":"A3","volume":"61","author":"JMJ Weaver","year":"2012","unstructured":"Weaver, J. M. J.  et al. OC-008 Defining the genetic landscape of oesopahgeal adenocarcinoma by next-generation sequencing. Gut 61 (Suppl. 2), A3\u2013A4 (2012).","journal-title":"Gut"},{"key":"BFnrgastro2013150_CR56","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/ng.2591","volume":"45","author":"AM Dulak","year":"2013","unstructured":"Dulak, A. M.  et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat. Genet. 45, 478\u2013486 (2013).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2013150_CR57","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1158\/0008-5472.CAN-11-3893","volume":"72","author":"AM Dulak","year":"2012","unstructured":"Dulak, A. M.  et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res. 72, 4383\u20134393 (2012).","journal-title":"Cancer Res."},{"key":"BFnrgastro2013150_CR58","doi-asserted-by":"publisher","unstructured":"Streppel, M. M.  et al. Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus. Oncogene \n                    http:\/\/dx.doi.org\/10.1038\/onc.2012.586\n                    \n                  .","DOI":"10.1038\/onc.2012.586"},{"key":"BFnrgastro2013150_CR59","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-5223(96)70441-5","volume":"111","author":"PM Schneider","year":"1996","unstructured":"Schneider, P. M.  et al. Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases. J. Thorac. Cardiovasc. Surg. 111, 323\u2013331; discussion 331\u2013333 (1996).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFnrgastro2013150_CR60","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/8816","volume":"22","author":"MT Barrett","year":"1999","unstructured":"Barrett, M. T.  et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat. Genet. 22, 106\u2013109 (1999).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2013150_CR61","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature09639","volume":"469","author":"I Varela","year":"2011","unstructured":"Varela, I.  et al. Exome sequencing identifies frequent mutation of the SWI\/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539\u2013542 (2011).","journal-title":"Nature"},{"key":"BFnrgastro2013150_CR62","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ng.2291","volume":"44","author":"A Fujimoto","year":"2012","unstructured":"Fujimoto, A.  et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat. Genet. 44, 760\u2013764 (2012).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2013150_CR63","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/ng.2246","volume":"44","author":"ZJ Zang","year":"2012","unstructured":"Zang, Z. J.  et al. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat. Genet. 44, 570\u2013574 (2012).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2013150_CR64","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","volume":"363","author":"KC Wiegand","year":"2010","unstructured":"Wiegand, K. C.  et al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N. Engl. J. Med. 363, 1532\u20131543 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2013150_CR65","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.cellsig.2011.08.011","volume":"24","author":"E Wertheimer","year":"2012","unstructured":"Wertheimer, E.  et al. Rac signaling in breast cancer: a tale of GEFs and GAPs. Cell Signal. 24, 353\u2013362 (2012).","journal-title":"Cell Signal."},{"key":"BFnrgastro2013150_CR66","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1126\/science.1145720","volume":"318","author":"LD Wood","year":"2007","unstructured":"Wood, L. D.  et al. The genomic landscapes of human breast and colorectal cancers. Science 318, 1108\u20131113 (2007).","journal-title":"Science"},{"key":"BFnrgastro2013150_CR67","doi-asserted-by":"crossref","unstructured":"TCGA. Comprehensive molecular portraits of human breast tumours. Nature 490, 61\u201370 (2012).","DOI":"10.1038\/nature11412"},{"key":"BFnrgastro2013150_CR68","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature09744","volume":"470","author":"MF Berger","year":"2011","unstructured":"Berger, M. F.  et al. The genomic complexity of primary human prostate cancer. Nature 470, 214\u2013220 (2011).","journal-title":"Nature"},{"key":"BFnrgastro2013150_CR69","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature11143","volume":"486","author":"MJ Ellis","year":"2012","unstructured":"Ellis, M. J.  et al. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 486, 353\u2013360 (2012).","journal-title":"Nature"},{"key":"BFnrgastro2013150_CR70","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis, C.  et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346\u2013352 (2012).","journal-title":"Nature"},{"key":"BFnrgastro2013150_CR71","unstructured":"International Cancer Genome Consortium. Esophageal cancer - esophageal adenocarcinoma. International Cancer Genome Consortium \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrgastro2013150_CR72","unstructured":"National Cancer Institute. The Cancer Genome Atlas \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrgastro2013150_CR73","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1200\/JCO.2012.45.9636","volume":"31","author":"CA Ong","year":"2013","unstructured":"Ong, C. A.  et al. Three-gene immunohistochemical panel adds to clinical staging algorithms to predict prognosis for patients with esophageal adenocarcinoma. J. Clin. Oncol. 31, 1576\u20131582 (2013).","journal-title":"J. Clin. Oncol."},{"key":"BFnrgastro2013150_CR74","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1158\/1078-0432.CCR-09-1673","volume":"16","author":"M Schauer","year":"2010","unstructured":"Schauer, M.  et al. Microarray-based response prediction in esophageal adenocarcinoma. Clin. Cancer Res. 16, 330\u2013337 (2010).","journal-title":"Clin. Cancer Res."},{"key":"BFnrgastro2013150_CR75","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1245\/s10434-008-0165-y","volume":"15","author":"SM Lagarde","year":"2008","unstructured":"Lagarde, S. M.  et al. Analysis of gene expression identifies differentially expressed genes and pathways associated with lymphatic dissemination in patients with adenocarcinoma of the esophagus. Ann. Surg. Oncol. 15, 3459\u20133470 (2008).","journal-title":"Ann. Surg. Oncol."},{"key":"BFnrgastro2013150_CR76","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1471-2164-7-278","volume":"7","author":"AM Glas","year":"2006","unstructured":"Glas, A. M.  et al. Converting a breast cancer microarray signature into a high-throughput diagnostic test. BMC Genomics 7, 278 (2006).","journal-title":"BMC Genomics"},{"key":"BFnrgastro2013150_CR77","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1470-2045(09)70314-6","volume":"11","author":"KS Albain","year":"2010","unstructured":"Albain, K. S.  et al. Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial. Lancet Oncol. 11, 55\u201365 (2010).","journal-title":"Lancet Oncol."},{"key":"BFnrgastro2013150_CR78","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/gut.2010.234179","volume":"60","author":"XY Goh","year":"2011","unstructured":"Goh, X. Y.  et al. Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma. Gut 60, 1317\u20131326 (2011).","journal-title":"Gut"},{"key":"BFnrgastro2013150_CR79","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal, S.  et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979\u2013993 (2012).","journal-title":"Cell"},{"key":"BFnrgastro2013150_CR80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccr.2012.11.010","volume":"23","author":"NL Sharma","year":"2013","unstructured":"Sharma, N. L.  et al. The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man. Cancer Cell 23, 35\u201347 (2013).","journal-title":"Cancer Cell"},{"key":"BFnrgastro2013150_CR81","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature10730","volume":"481","author":"CS Ross-Innes","year":"2012","unstructured":"Ross-Innes, C. S.  et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481, 389\u2013393 (2012).","journal-title":"Nature"},{"key":"BFnrgastro2013150_CR82","doi-asserted-by":"crossref","first-page":"e1001356","DOI":"10.1371\/journal.pgen.1001356","volume":"7","author":"H Alvarez","year":"2011","unstructured":"Alvarez, H.  et al. Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis. PLoS Genet. 7, e1001356 (2011).","journal-title":"PLoS Genet."},{"key":"BFnrgastro2013150_CR83","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1245\/s10434-012-2848-7","volume":"20","author":"R Parameswaran","year":"2013","unstructured":"Parameswaran, R.  et al. Assessment and comparison of recovery after open and minimally invasive esophagectomy for cancer: an exploratory study in two centers. Ann. Surg. Oncol. 20, 1970\u20131977 (2013).","journal-title":"Ann. Surg. Oncol."},{"key":"BFnrgastro2013150_CR84","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/annonc\/mdn716","volume":"20","author":"I Chau","year":"2009","unstructured":"Chau, I.  et al. The impact of primary tumour origins in patients with advanced oesophageal, oesophago-gastric junction and gastric adenocarcinoma\u2014individual patient data from 1775 patients in four randomised controlled trials. Ann. Oncol. 20, 885\u2013891 (2009).","journal-title":"Ann. Oncol."},{"key":"BFnrgastro2013150_CR85","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ng.982","volume":"43","author":"K Wang","year":"2011","unstructured":"Wang, K.  et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer. Nat. Genet. 43, 1219\u20131223 (2011).","journal-title":"Nat. Genet."},{"key":"BFnrgastro2013150_CR86","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/gb-2012-13-12-r115","volume":"13","author":"N Nagarajan","year":"2012","unstructured":"Nagarajan, N.  et al. Whole-genome reconstruction and mutational signatures in gastric cancer. Genome Biol. 13, R115 (2012).","journal-title":"Genome Biol."},{"key":"BFnrgastro2013150_CR87","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1200\/JCO.2012.43.3755","volume":"31","author":"JD Hainsworth","year":"2013","unstructured":"Hainsworth, J. D.  et al. Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute. J. Clin. Oncol. 31, 217\u2013223 (2013).","journal-title":"J. Clin. Oncol."},{"key":"BFnrgastro2013150_CR88","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","volume":"363","author":"KT Flaherty","year":"2010","unstructured":"Flaherty, K. T.  et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N. Engl. J. Med. 363, 809\u2013819 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2013150_CR89","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/path.4044","volume":"230","author":"AL Paterson","year":"2013","unstructured":"Paterson, A. L.  et al. Characterization of the timing and prevalence of receptor tyrosine kinase expression changes in oesophageal carcinogenesis. J. Pathol. 230, 118\u2013128 (2013).","journal-title":"J. Pathol."},{"key":"BFnrgastro2013150_CR90","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1158\/1078-0432.CCR-06-1970","volume":"13","author":"DR Ferry","year":"2007","unstructured":"Ferry, D. R.  et al. A phase II study of gefitinib monotherapy in advanced esophageal adenocarcinoma: evidence of gene expression, cellular, and clinical response. Clin. Cancer Res. 13, 5869\u20135875 (2007).","journal-title":"Clin. Cancer Res."},{"key":"BFnrgastro2013150_CR91","first-page":"2781","volume":"17","author":"RR Keld","year":"2011","unstructured":"Keld, R. R. & Ang, Y. S. Targeting key signalling pathways in oesophageal adenocarcinoma: a reality for personalised medicine? World J. Gastroenterol. 17, 2781\u20132790 (2011).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2013150_CR92","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang, Y. J.  et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376, 687\u2013697 (2010).","journal-title":"Lancet"},{"key":"BFnrgastro2013150_CR93","unstructured":"ISRCTN. Current Controlled Trials \n                    [online]\n                    \n                  , (2013)."},{"key":"BFnrgastro2013150_CR94","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2012)."},{"key":"BFnrgastro2013150_CR95","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/archsurg.142.6.533","volume":"142","author":"F Banki","year":"2007","unstructured":"Banki, F.  et al. Plasma DNA as a molecular marker for completeness of resection and recurrent disease in patients with esophageal cancer. Arch. Surg. 142, 533\u2013538 (2007).","journal-title":"Arch. Surg."},{"key":"BFnrgastro2013150_CR96","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa1213261","volume":"368","author":"SJ Dawson","year":"2013","unstructured":"Dawson, S. J.  et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N. Engl. J. Med. 368, 1199\u20131209 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2013150_CR97","doi-asserted-by":"crossref","first-page":"136ra68","DOI":"10.1126\/scitranslmed.3003726","volume":"4","author":"T Forshew","year":"2012","unstructured":"Forshew, T.  et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med. 4, 136ra68 (2012).","journal-title":"Sci. Transl. Med."},{"key":"BFnrgastro2013150_CR98","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nm.1789","volume":"14","author":"F Diehl","year":"2008","unstructured":"Diehl, F.  et al. Circulating mutant DNA to assess tumor dynamics. Nat. Med. 14, 985\u2013990 (2008).","journal-title":"Nat. Med."},{"key":"BFnrgastro2013150_CR99","doi-asserted-by":"crossref","first-page":"20ra14","DOI":"10.1126\/scitranslmed.3000702","volume":"2","author":"RJ Leary","year":"2010","unstructured":"Leary, R. J.  et al. Development of personalized tumor biomarkers using massively parallel sequencing. Sci. Transl. Med. 2, 20ra14 (2010).","journal-title":"Sci. Transl. Med."},{"key":"BFnrgastro2013150_CR100","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1593\/neo.111626","volume":"14","author":"R Zhai","year":"2012","unstructured":"Zhai, R.  et al. Genome-wide DNA methylation profiling of cell-free serum DNA in esophageal adenocarcinoma and Barrett esophagus. Neoplasia 14, 29\u201333 (2012).","journal-title":"Neoplasia"},{"key":"BFnrgastro2013150_CR101","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","volume":"105","author":"PS Mitchell","year":"2008","unstructured":"Mitchell, P. S.  et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl Acad. Sci. USA 105, 10513\u201310518 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrgastro2013150_CR102","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen, X.  et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 18, 997\u20131006 (2008).","journal-title":"Cell Res."},{"key":"BFnrgastro2013150_CR103","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ajg.2011.37","volume":"106","author":"A Bansal","year":"2011","unstructured":"Bansal, A.  et al. Feasibility of mcroRNAs as biomarkers for Barrett's esophagus progression: a pilot cross-sectional, phase 2 biomarker study. Am. J. Gastroenterol. 106, 1055\u20131063 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2013150_CR104","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1158\/1078-0432.CCR-09-0385","volume":"15","author":"H Yang","year":"2009","unstructured":"Yang, H.  et al. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clin. Cancer Res. 15, 5744\u20135752 (2009).","journal-title":"Clin. Cancer Res."},{"key":"BFnrgastro2013150_CR105","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger, M.  et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883\u2013892 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2013150_CR106","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature11219","volume":"486","author":"LA Diaz Jr","year":"2012","unstructured":"Diaz, L. A., Jr  et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486, 537\u2013540 (2012).","journal-title":"Nature"},{"key":"BFnrgastro2013150_CR107","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11156","volume":"486","author":"S Misale","year":"2012","unstructured":"Misale, S.  et al. Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature 486, 532\u2013536 (2012).","journal-title":"Nature"},{"key":"BFnrgastro2013150_CR108","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/gm205","volume":"2","author":"ER Mardis","year":"2010","unstructured":"Mardis, E. R. The $1,000 genome, the $100,000 analysis? Genome Med. 2, 84 (2010).","journal-title":"Genome Med."}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.150","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:48:09Z","timestamp":1684468089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2013.150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,27]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["BFnrgastro2013150"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2013.150","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,27]]}}}